tiprankstipranks
Analyst Profile
Followed by 284 other investors
.
Myles Minter

Myles Minter

William Blair
Wall Street Analyst
Ranked #1,932 out of 8,050 Analysts on TipRanks (#3,625 out of 21,576 overall experts)

Success Rate

45%
44 out of 97 Profitable Transactions

Average Return

8.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Myles Minter's ratings since 2021 and opened each position for the duration of 1 Year:
45.36% of your transactions would have been profitable with an average return of 8.8%

Stock Rating Distribution

172Ratings
80.81% Buy
19.19% Hold
0.00% Sell
Distribution of Myles Minter's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Axsome Therapeutics Inc.
(AXSM)
Rating Type:Buy
Dates:Sep 27, 2019 - Sep 27, 2020
Gain:248.60%
The most profitable rating made by Myles Minter

Myles Minter's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
PRVL
Prevail Therapeutics
Jan 22, 2021
Hold
Reiterated
100%
+113.60%
5
TBIO
Translate Bio
Aug 03, 2021
Hold
Downgraded
100%
+110.67%
13
Praxis Precision Medicines
Aug 16, 2021
Buy
Reiterated
0%
-77.05%
4
Minerva Neurosciences
Sep 30, 2021
Hold
Reiterated
0%
-48.90%
14
Silence Therapeutics
Oct 22, 2021
Buy
Reiterated
40%
-15.14%
15
Alector
Nov 15, 2021
Buy
Reiterated
0%
-43.65%
2
Ionis Pharmaceuticals
Dec 14, 2021
Buy
Upgraded
100%
+46.80%
21
Biogen
Jan 03, 2022
Buy
Reiterated
0%
-10.85%
5
Neurocrine
Jan 07, 2022
Buy
Reiterated
43%
-0.64%
20
Bionomics
Jan 10, 2022
Buy
Initiated
$40.00
(462.59% Upside)
0%
-39.40%
1
List of latest recommendations made by Myles Minter. Click to expand and see Myles Minter's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More